Download
1 / 4
40 likes | 46 Views
The transdermal drug delivery system market was valued at US$5.914 billion in 2019 and is expected to grow at a CAGR of 4.71% over the forecast period to reach a total market size of US$8.162 billion by 2026. The developing patient inclination for the torment-free prescription organization has brought about an impressive expansion in the reception pace of medication overseeing adhesive skin patches, as would be considered normal to offer the market solid development potential.<br>
E N D
Transdermal Drug Delivery Systems (TDDS) Market is projected to grow at a CAGR of 4.71% by 2026 Introduction The transdermal drug delivery system market was valued at US$5.914 billion in 2019 and is expected to grow at a CAGR of 4.71% over the forecast period to reach a total market size of US$8.162 billion by 2026. The developing patient inclination for the torment-free prescription organization has brought about an impressive expansion in the reception pace of medication overseeing adhesive skin patches, as would be considered normal to offer the market solid development potential. Segmentation The transdermal drug delivery system market has been segmented on the basis of application, type, end-user, and geography. Table of Content 1. Introduction 1.1. Market Definition 1.2. Market Segmentation 2. Research Methodology 2.1. Research Data 2.2. Assumptions 3. Executive Summary 3.1. Research Highlights
4. Market Dynamics 4.1. Market Drivers 4.2. Market Restraints 4.3. Porters Five Forces Analysis 4.3.1. Bargaining Power of Suppliers 4.3.2. Bargaining Power of Buyers 4.3.3. The threat of New Entrants 4.3.4. Threat of Substitutes 4.3.5. Competitive Rivalry in the Industry 4.4. Industry Value Chain Analysis 5. Transdermal Drug Delivery Systems Market Analysis, By Type 5.1. Introduction 5.2. Patches 5.3. Gels & Ointments 6. Transdermal Drug Delivery Systems Market Analysis, By Application 6.1. Introduction 6.2. Neurologic Conditions 6.3. Pain Management 6.4. Nicotine Cessation 6.5. Cardiovascular 6.6. Others 7. Transdermal Drug Delivery Systems Market Analysis, By End-User 7.1. Introduction 7.2. Hospitals & Clinics 7.3. Surgical Centers 7.4. Home Care Settings 8. Transdermal Drug Delivery Systems Market Analysis, By Geography 8.1. Introduction
8.2. North America 8.2.1. United States 8.2.2. Canada 8.2.3. Mexico 8.3. South America 8.3.1. Brazil 8.3.2. Argentina 8.3.3. Others 8.4. Europe 8.4.1. UK 8.4.2. France 8.4.3. Germany 8.4.4. Italy 8.4.5. Others 8.5. Middle East and Africa 8.5.1. Saudi Arabia 8.5.2. UAE 8.5.3. Others 8.6. Asia Pacific 8.6.1. Japan 8.6.2. China 8.6.3. India 8.6.4. Thailand 8.6.5. Taiwan 8.6.6. Indonesia 8.6.7. Others 9. Competitive Environment and Analysis 9.1. Major Players and Strategy Analysis 9.2. Emerging Players and Market Lucrativeness 9.3. Mergers, Acquisitions, Agreements, and Collaborations 9.4. Vendor Competitiveness Matrix 10. Company Profiles 10.1. 3M 10.2. ProSolus Inc. 10.3. Zosano Pharma Corporation 10.4. Medherant Ltd.
10.5. Tapemark 10.6. Toyochem Co. Ltd. 10.7. LivCorp Inc. 10.8. Epinamics GmbH 10.9. AdhexPharma 10.10. Sparsha Pharma International Pvt Ltd. Request Free Sample or Download Full Report: transdermal drug delivery system market TO ORDER OR REQUEST FOR A SAMPLE: PRODUCT: Transdermal Drug Delivery Systems Market - Forecasts From 2021 To 2026 Price: US$3,950 – Single User License US$4,550 – Multi User License US$6,950 – Enterprise License To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with the payment. For wire transfer, write to us at sales@knowledge-sourcing.com For any custom requirements or queries, please visit our website or call us: Website: https://www.knowledge-sourcing.com Contact us: Address: Assotech Business Cresterra, Upper Ground Floor Tower 2, Plot No 22, Sector 135, Noida 201301 Uttar Pradesh, India Email: info@knowledge-sourcing.com Phone: +1-850-250-1698 Follow us: Facebook Linkedin Twitter
